Published in Medical Letter on the CDC and FDA, April 4th, 2004
According to a researcher in Canada, "The question of the use of the placebo is one of the most controversial in the field of the ethics of research today. The use of the placebo remains the standard practice of biomedical research in spite of the fact that various revisions of the Helsinki Declaration have sought to limit its use."
"The positions taken by the various ethical decision-making bodies are, however, hardly shared by regulatory bodies such as the Food and Drug Administration (FDA), the Council for International Organization...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.